BeyondSpring's Plinabulin Shows Promising Survival Benefits in Lung Cancer and Strategic Advances in Protein Degradation
BeyondSpring's Plinabulin demonstrated statistically significant survival benefits in second and third-line non-small cell lung cancer (EGFR wild-type) patients, with results published in The Lancet Respiratory Medicine.